Resources search

Access to medicines in under-served markets : what are the implications of changes in intellectual property rights, trade and drug registration policy?

DFID HEALTH SYSTEMS RESOURCE CENTRE (HSRC)
September 2004

Expand view

This overview draws on seven studies commissioned by the UK's Department for International Development. After providing some background, it considers the implications of stronger intellectual property protection for access to medicines; the prospects for supply in emerging and under-served markets; and makes recommendations for increasing access

Emerging challenges and opportunities in drug registration and regulation in developing countries

HILL, Suzanne
JOHNSON, Kent
May 2004

Expand view

This study describes current drug regulation and registration processes in selected countries, in order to understand how they affect the quality and availability of medicines in developing countries. It puts forward policy recommendations as to how systems can more efficiently allow appropriate quality drugs to be marketed and examines the emerging challenges and requirements posed by compulsory licensing, drugs for neglected diseases, anti-retroviral (ARV) and anti-tuberculosis (TB) drugs

E-bulletin